We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Epilogue: New Drugs for Neglected Diseases.
- Authors
POGGE, THOMAS; HOLLIS, AIDAN
- Abstract
In a widely cited 2003 article, DiMasi, Hansen, and Grabowski estimated the cost of pharmaceutical research and development to be $1.1 billion (year 2000 U.S. dollars) per new medicine coming onto the market in 2001. They also estimate that this cost is going up at a real (inflation-adjusted) rate of 7.4% annually. According to these estimates, the innovation cost per new medicine today is about $2.1 billion (year 2000 U.S. dollars) or $2.65 billion (year 2010 U.S. dollars).
- Subjects
DRUGS &; economics; DRUG laws; INTELLECTUAL property; PHARMACEUTICAL industry &; economics; HEALTH services accessibility; POVERTY; WORLD health; HUMANITARIAN assistance; DRUG development; GOVERNMENT aid; INTERNATIONAL cooperation; ECONOMICS
- Publication
Cambridge Quarterly of Healthcare Ethics, 2011, Vol 20, Issue 2, p329
- ISSN
0963-1801
- Publication type
Article
- DOI
10.1017/S0963180110000988